{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,4,17]],"date-time":"2026-04-17T22:35:57Z","timestamp":1776465357515,"version":"3.51.2"},"reference-count":35,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2025,4,1]],"date-time":"2025-04-01T00:00:00Z","timestamp":1743465600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2025,4,1]],"date-time":"2025-04-01T00:00:00Z","timestamp":1743465600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2025,1,6]],"date-time":"2025-01-06T00:00:00Z","timestamp":1736121600000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"funder":[{"DOI":"10.13039\/100012238","name":"Frederick Gardner Cottrell Foundation","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100012238","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Bioorganic &amp; Medicinal Chemistry Letters"],"published-print":{"date-parts":[[2025,4]]},"DOI":"10.1016\/j.bmcl.2025.130095","type":"journal-article","created":{"date-parts":[[2025,1,6]],"date-time":"2025-01-06T17:20:41Z","timestamp":1736184041000},"page":"130095","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":3,"special_numbering":"C","title":["Synthesis of novel pyrrolobenzodiazepine (PBD) C1-substituted monomers and dimers with DNA-binding activity and cytotoxicity"],"prefix":"10.1016","volume":"119","author":[{"given":"George","family":"Procopiou","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Paul J.M.","family":"Jackson","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Paolo","family":"Andriollo","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Md. Mahbub","family":"Hasan","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Nicolas","family":"Veillard","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Khondaker Miraz","family":"Rahman","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-8032-7203","authenticated-orcid":false,"given":"David E.","family":"Thurston","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"key":"10.1016\/j.bmcl.2025.130095_b0005","doi-asserted-by":"crossref","first-page":"5791","DOI":"10.1021\/ja00952a050","article-title":"Isolation and characterization of anthramycin, a new antitumor antibiotic","volume":"87","author":"Leimgruber","year":"1965","journal-title":"J Am Chem Soc"},{"key":"10.1016\/j.bmcl.2025.130095_b0010","doi-asserted-by":"crossref","first-page":"433","DOI":"10.1021\/cr00026a006","article-title":"Synthesis of DNA-interactive pyrrolo[2,1-c][1,4]benzodiazepines","volume":"94","author":"Thurston","year":"1994","journal-title":"Chem Rev"},{"key":"10.1016\/j.bmcl.2025.130095_b0015","doi-asserted-by":"crossref","first-page":"2815","DOI":"10.1021\/cr100120f","article-title":"Synthesis of DNA-interactive pyrrolo[2,1-c][1,4]benzodiazepines (PBDs)","volume":"111","author":"Antonow","year":"2011","journal-title":"Chem Rev"},{"key":"10.1016\/j.bmcl.2025.130095_b0020","doi-asserted-by":"crossref","first-page":"462","DOI":"10.1002\/anie.201510610","article-title":"From anthramycin to pyrrolobenzodiazepine (PBD)-containing antibody\u2013drug conjugates (ADCs)","volume":"56","author":"Mantaj","year":"2017","journal-title":"Angew Chem Int Ed"},{"key":"10.1016\/j.bmcl.2025.130095_b0025","doi-asserted-by":"crossref","first-page":"2911","DOI":"10.1021\/jm301882a","article-title":"GC-targeted C8-linked pyrrolobenzodiazepine\u2013biaryl conjugates with femtomolar in vitro cytotoxicity and in vivo antitumor activity in mouse models","volume":"56","author":"Rahman","year":"2013","journal-title":"J Med Chem"},{"key":"10.1016\/j.bmcl.2025.130095_b0030","doi-asserted-by":"crossref","first-page":"5105","DOI":"10.1016\/S0040-4039(00)80691-7","article-title":"Synthesis and DNA crosslinking ability of a dimeric anthramycin analog","volume":"29","author":"Farmer","year":"1988","journal-title":"Tetrahedron Lett"},{"key":"10.1016\/j.bmcl.2025.130095_b0035","doi-asserted-by":"crossref","first-page":"833","DOI":"10.1007\/s00280-009-1088-4","article-title":"A phase I trial of SJG-136 (NSC#694501) in advanced solid tumors","volume":"65","author":"Janjigian","year":"2010","journal-title":"Cancer Chemother Pharmacol"},{"key":"10.1016\/j.bmcl.2025.130095_b0040","first-page":"225","article-title":"Design, synthesis and in vitro cytotoxicity studies of novel pyrrolo[2,1-c][1,4]benzodiazepine (PBD)\u2013polymade conjugates and 2,2'-PBD dimers","volume":"15","author":"Reddy","year":"2000","journal-title":"Anticancer Drug Des"},{"key":"10.1016\/j.bmcl.2025.130095_b0045","doi-asserted-by":"crossref","first-page":"737","DOI":"10.1021\/jm001064n","article-title":"Design, synthesis, and evaluation of a novel pyrrolobenzodiazepine DNA-interactive agent with highly efficient cross-linking ability and potent cytotoxicity","volume":"44","author":"Gregson","year":"2001","journal-title":"J Med Chem"},{"key":"10.1016\/j.bmcl.2025.130095_b0050","doi-asserted-by":"crossref","first-page":"1319","DOI":"10.1158\/1535-7163.MCT-07-0475","article-title":"Inhibition of DNA binding of the NF-Y transcription factor by the pyrrolobenzodiazepine-polyamide conjugate GWL-78","volume":"7","author":"Kotecha","year":"2008","journal-title":"Mol Cancer Ther"},{"key":"10.1016\/j.bmcl.2025.130095_b0055","doi-asserted-by":"crossref","first-page":"3671","DOI":"10.1093\/nar\/21.16.3671","article-title":"A quantitative assay to measure the relative DNA-binding affinity of pyrrolo[2,1-c][1,4]benzodiazepine (PBD) antitumour antibiotics based on the inhibition of restriction endonuclease BamhI","volume":"21","author":"Puvvada","year":"1993","journal-title":"Nucleic Acids Res"},{"key":"10.1016\/j.bmcl.2025.130095_b0060","doi-asserted-by":"crossref","first-page":"59","DOI":"10.1016\/j.ejmech.2015.12.039","article-title":"Design and synthesis of pyrrolobenzodiazepine-gallic hybrid agents as p53-dependent and -independent apoptogenic signaling in melanoma cells","volume":"109","author":"Chou","year":"2016","journal-title":"Eur J Med Chem"},{"key":"10.1016\/j.bmcl.2025.130095_b0065","doi-asserted-by":"crossref","first-page":"215","DOI":"10.1186\/s12917-015-0534-2","article-title":"Activity of the DNA minor groove cross-linking agent SG2000 (SJG-136) against canine tumours","volume":"11","author":"Mellinas-Gomez","year":"2015","journal-title":"BMC Vet Res"},{"key":"10.1016\/j.bmcl.2025.130095_b0070","doi-asserted-by":"crossref","first-page":"2140","DOI":"10.1158\/1078-0432.CCR-08-1315","article-title":"Phase I study of sequence-selective minor groove DNA binding agent SJG-136 in patients with advanced solid tumors","volume":"15","author":"Hochhauser","year":"2009","journal-title":"Clin Cancer Res"},{"key":"10.1016\/j.bmcl.2025.130095_b0075","series-title":"Cytotoxic payloads for antibody\u2013drug conjugates","first-page":"296","author":"Gregson","year":"2019"},{"key":"10.1016\/j.bmcl.2025.130095_b0080","doi-asserted-by":"crossref","first-page":"5510","DOI":"10.3390\/ijms21155510","article-title":"Antibody-drug conjugates: the new frontier of chemotherapy","volume":"21","author":"Ponziani","year":"2020","journal-title":"Int J Mol Sci"},{"key":"10.1016\/j.bmcl.2025.130095_b0085","first-page":"1","article-title":"Antibody-drug conjugates (ADCs) delivering pyrrolobenzodiazepine (PBD) dimers for cancer therapy","author":"Hartley","year":"2020","journal-title":"Expert Opin Biol Ther"},{"key":"10.1016\/j.bmcl.2025.130095_b0090","doi-asserted-by":"crossref","DOI":"10.3390\/ph13090245","article-title":"Antibody\u2013drug conjugates: the last decade","volume":"13","author":"Joubert","year":"2020","journal-title":"Pharmaceuticals"},{"key":"10.1016\/j.bmcl.2025.130095_b0095","unstructured":"FDA grants accelerated approval to loncastuximab tesirine-lpyl for large B-cell lymphoma; 2021. <https:\/\/www.fda.gov\/drugs\/fda-grants-accelerated-approval-loncastuximab-tesirine-lpyl-large-b-cell-lymphoma>."},{"key":"10.1016\/j.bmcl.2025.130095_b0100","first-page":"814","article-title":"Cancer stem cell candidate Rova-T discontinued","volume":"18","author":"Mullard","year":"2019","journal-title":"Nat Rev Drug Discov"},{"key":"10.1016\/j.bmcl.2025.130095_b0105","doi-asserted-by":"crossref","DOI":"10.1016\/j.yrtph.2019.104429","article-title":"An FDA oncology analysis of toxicities associated with PBD-containing antibody-drug conjugates","volume":"107","author":"Saber","year":"2019","journal-title":"Regul Toxicol Pharm"},{"key":"10.1016\/j.bmcl.2025.130095_b0110","doi-asserted-by":"crossref","DOI":"10.1016\/j.jchromb.2020.122075","article-title":"UPLC-based assay to assess the hydrophobicity of Antibody-Drug Conjugate (ADC) payloads","volume":"1146","author":"Pysz","year":"2020","journal-title":"J Chromatogr B"},{"key":"10.1016\/j.bmcl.2025.130095_b0115","doi-asserted-by":"crossref","first-page":"3041","DOI":"10.1016\/j.bmc.2007.01.054","article-title":"Synthesis of a novel C2-aryl pyrrolo[2,1-c][1,4]benzodiazepine-5,11-dione library: effect of C2-aryl substitution on cytotoxicity and non-covalent DNA binding","volume":"15","author":"Antonow","year":"2007","journal-title":"Bioorg Med Chem"},{"key":"10.1016\/j.bmcl.2025.130095_b0120","first-page":"2875","article-title":"New pyrrolobenzodiazepine antibiotics, RK-1441A and B. I. Biological properties","volume":"54","author":"Osada","year":"1990","journal-title":"Agric Biol Chem"},{"key":"10.1016\/j.bmcl.2025.130095_b0125","doi-asserted-by":"crossref","first-page":"52","DOI":"10.1023\/A:1016395113085","article-title":"Pyrrolo(l ,4)benzodiazepine antitumor antibiotics: chemistry, interaction with DNA, and biological implications","volume":"1","author":"Hurley","year":"1984","journal-title":"Pharm Res"},{"key":"10.1016\/j.bmcl.2025.130095_b0130","doi-asserted-by":"crossref","first-page":"275","DOI":"10.1002\/j.1552-4604.1965.tb00247.x","article-title":"Clinical investigation of cancer chemotherapeutic agents for neoplastic disease","volume":"5","author":"Korman","year":"1965","journal-title":"J New Drugs"},{"key":"10.1016\/j.bmcl.2025.130095_b0135","doi-asserted-by":"crossref","first-page":"1518","DOI":"10.1039\/c39920001518","article-title":"Effect of linker length on DNA-binding affinity, cross-linking efficiency and cytotoxicity of C8-linked pyrrolobenzodiazepine dimers","author":"Bose","year":"1992","journal-title":"J Chem Soc Chem Commun"},{"key":"10.1016\/j.bmcl.2025.130095_b0140","doi-asserted-by":"crossref","first-page":"19902","DOI":"10.1021\/jacs.9b11262","article-title":"Site-selective and stereoselective O-alkylation of glycosides by Rh(II)-catalyzed carbenoid insertion","volume":"141","author":"Wu","year":"2019","journal-title":"J Am Chem Soc"},{"key":"10.1016\/j.bmcl.2025.130095_b0145","doi-asserted-by":"crossref","first-page":"2167","DOI":"10.1016\/0040-4020(94)01070-G","article-title":"Two-directional synthesis and its use in natural product synthesis","volume":"51","author":"Magnuson","year":"1995","journal-title":"Tetrahedron"},{"key":"10.1016\/j.bmcl.2025.130095_b0150","doi-asserted-by":"crossref","first-page":"13756","DOI":"10.1021\/ja902986x","article-title":"The pyrrolobenzodiazepine dimer SJG-136 forms sequence-dependent intrastrand DNA cross-links and monoalkylated adducts in addition to interstrand cross-links","volume":"131","author":"Rahman","year":"2009","journal-title":"J Am Chem Soc"},{"key":"10.1016\/j.bmcl.2025.130095_b0155","doi-asserted-by":"crossref","first-page":"4135","DOI":"10.1021\/bi0479813","article-title":"Sequence-selective interaction of the minor-groove interstrand cross-linking agent SJG-136 with naked and cellular DNA: footprinting and enzyme inhibition studies","volume":"44","author":"Martin","year":"2005","journal-title":"Biochemistry"},{"key":"10.1016\/j.bmcl.2025.130095_b0160","doi-asserted-by":"crossref","first-page":"173","DOI":"10.1016\/j.ab.2007.11.018","article-title":"An assay combining high-performance liquid chromatography and mass spectrometry to measure DNA interstrand cross-linking efficiency in oligonucleotides of varying sequences","volume":"374","author":"Narayanaswamy","year":"2008","journal-title":"Anal Biochem"},{"key":"10.1016\/j.bmcl.2025.130095_b0165","doi-asserted-by":"crossref","first-page":"5800","DOI":"10.1093\/nar\/gkr122","article-title":"Effect of base sequence on the DNA cross-linking properties of pyrrolobenzodiazepine (PBD) dimers","volume":"39","author":"Rahman","year":"2011","journal-title":"Nucleic Acids Res"},{"key":"10.1016\/j.bmcl.2025.130095_b0170","doi-asserted-by":"crossref","first-page":"2127","DOI":"10.1021\/acs.jmedchem.8b01849","article-title":"Effects of systematic shortening of noncovalent C8 side chain on the cytotoxicity and NF-\u03baB inhibitory capacity of pyrrolobenzodiazepines (PBDs)","volume":"62","author":"Corcoran","year":"2019","journal-title":"J Med Chem"},{"key":"10.1016\/j.bmcl.2025.130095_b0175","doi-asserted-by":"crossref","first-page":"71","DOI":"10.1016\/j.ddtec.2018.10.004","article-title":"Use of pyrrolobenzodiazepines and related covalent-binding DNA-interactive molecules as ADC payloads: is mechanism related to systemic toxicity?","volume":"30","author":"Jackson","year":"2018","journal-title":"Drug Discov Today Technol"}],"container-title":["Bioorganic &amp; Medicinal Chemistry Letters"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0960894X25000046?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0960894X25000046?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,2,25]],"date-time":"2025-02-25T03:38:39Z","timestamp":1740454719000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0960894X25000046"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,4]]},"references-count":35,"alternative-id":["S0960894X25000046"],"URL":"https:\/\/doi.org\/10.1016\/j.bmcl.2025.130095","relation":{},"ISSN":["0960-894X"],"issn-type":[{"value":"0960-894X","type":"print"}],"subject":[],"published":{"date-parts":[[2025,4]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Synthesis of novel pyrrolobenzodiazepine (PBD) C1-substituted monomers and dimers with DNA-binding activity and cytotoxicity","name":"articletitle","label":"Article Title"},{"value":"Bioorganic & Medicinal Chemistry Letters","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.bmcl.2025.130095","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2025 The Author(s). Published by Elsevier Ltd.","name":"copyright","label":"Copyright"}],"article-number":"130095"}}